GUAIFENESIN
NDC 62207-569, GUAIFENESIN, tablet, extended release, from Granules India Ltd.
- Product NDC
- 62207-569
- Status
- Listed
- Labeler
- Granules India Ltd
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62207-569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN1200 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62207-569-93 | 62207056993 | 5 POUCH in 1 BOX (62207-569-93) / 2000 TABLET, EXTENDED RELEASE in 1 POUCH |
| 62207-569-99 | 62207056999 | 4200 TABLET, EXTENDED RELEASE in 1 BAG (62207-569-99) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62207-569 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62207-569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62207-569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.